These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 8780593)

  • 1. How do you spell relief in reflux esophagitis? PPI!
    Fennerty MB
    Gastroenterology; 1996 Sep; 111(3):826-7. PubMed ID: 8780593
    [No Abstract]   [Full Text] [Related]  

  • 2. Proton pump inhibitors or histamine-2 receptor antagonists for the prevention of recurrences of erosive reflux esophagitis: a cost-effectiveness analysis.
    Harris RA; Kuppermann M; Richter JE
    Am J Gastroenterol; 1997 Dec; 92(12):2179-87. PubMed ID: 9399748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Proton-pump inhibitor-first" strategy versus "step-up" strategy for the acute treatment of reflux esophagitis: a cost-effectiveness analysis in Japan.
    Habu Y; Maeda K; Kusuda T; Yoshino T; Shio S; Yamazaki M; Hayakumo T; Hayashi K; Watanabe Y; Kawai K
    J Gastroenterol; 2005 Nov; 40(11):1029-35. PubMed ID: 16322946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimum management of mild esophagitis in Japan.
    Sugano K
    J Gastroenterol; 1999 Aug; 34(4):540-1. PubMed ID: 10452692
    [No Abstract]   [Full Text] [Related]  

  • 5. Towards an increased efficacy of acid inhibition in the treatment of erosive oesophagitis.
    Lambert R
    J Gastroenterol Hepatol; 1996 Oct; 11(10):897-9. PubMed ID: 8912122
    [No Abstract]   [Full Text] [Related]  

  • 6. [An evidence-based look at pharmacotherapy for gastroesophageal reflux].
    Koop H
    Chirurg; 2005 Apr; 76(4):353-8. PubMed ID: 15309265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antisecretory therapy for bleeding peptic ulcer.
    Peterson WL; Cook DJ
    JAMA; 1998 Sep; 280(10):877-8. PubMed ID: 9739959
    [No Abstract]   [Full Text] [Related]  

  • 8. [H2 receptor antagonists and proton pump inhibitors: principles and rules of use].
    Bardou M
    Rev Prat; 2001 Apr; 51(7):789-95. PubMed ID: 11387678
    [No Abstract]   [Full Text] [Related]  

  • 9. The use of omeprazole for resistant oesophagitis in children.
    Martin PB; Imong SM; Krischer J; Noblett HR; Sandhu BK
    Eur J Pediatr Surg; 1996 Aug; 6(4):195-7. PubMed ID: 8877348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lansoprazol].
    Ponce J; Nos P
    Gastroenterol Hepatol; 1995 Feb; 18(2):101-9. PubMed ID: 7621274
    [No Abstract]   [Full Text] [Related]  

  • 11. Lansoprazole and omeprazole in the treatment of acid peptic disorders.
    Blum RA
    Am J Health Syst Pharm; 1996 Jun; 53(12):1401-15. PubMed ID: 8781686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the effects of omeprazole and famotidine in treatment of upper abdominal symptoms in patients with reflux esophagitis.
    Kusunoki H; Kusaka M; Kido S; Yamauchi R; Fujimura Y; Watanabe Y; Kobori M; Miwa H; Tomita T; Kin Y; Hori K; Tano N; Sugimoto K; Nakamura Y; Fujimoto K; Oza N; Matsunobu A; Ono N; Fuyuno S; Kinoshita Y; Adachi K; Yuki M; Fujisawa T; Haruma K
    J Gastroenterol; 2009; 44(4):261-70. PubMed ID: 19280112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Omeprazole in infants with cimetidine-resistant peptic esophagitis.
    Alliët P; Raes M; Bruneel E; Gillis P
    J Pediatr; 1998 Feb; 132(2):352-4. PubMed ID: 9506656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A randomized, prospective, comparative, multicenter study of rabeprazole and ranitidine in the treatment of reflux esophagitis].
    Jeong HY; Lee BS; Sung JK; Lee TY; Yoon SJ; Kim SJ; Chung IK; Lee SH; Shin JE; Lee DS; Baek JT; Nam SW; Yoon SJ; Kim SH; Lee GS; Lee JM; Kim AN; Oh JI
    Korean J Gastroenterol; 2006 Jan; 47(1):15-21. PubMed ID: 16434864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Symptom relief in gastroesophageal reflux disease: a randomized, controlled comparison of pantoprazole and nizatidine in a mixed patient population with erosive esophagitis or endoscopy-negative reflux disease.
    Armstrong D; Paré P; Pericak D; Pyzyk M;
    Am J Gastroenterol; 2001 Oct; 96(10):2849-57. PubMed ID: 11695354
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A practice-based approach for converting from proton pump inhibitors to less costly therapy.
    Lucas LM; Gerrity MS; Anderson T
    Eff Clin Pract; 2001; 4(6):263-70. PubMed ID: 11769299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacological efficacy of bismuth tripotassium dicitrate in peptic ulcer].
    Belousov IuB; Karpov OI; Belousov DIu; Beketov AS
    Ter Arkh; 2007; 79(2):58-66. PubMed ID: 17460971
    [No Abstract]   [Full Text] [Related]  

  • 18. Long-term therapy for reflux esophagitis.
    Tytgat GN
    N Engl J Med; 1995 Oct; 333(17):1148-50. PubMed ID: 7565956
    [No Abstract]   [Full Text] [Related]  

  • 19. [Long-term results of conservative management of reflux esophagitis].
    Viani F; Dorta G
    Ther Umsch; 2001 Mar; 58(3):146-50. PubMed ID: 11305152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reflux esophagitis.
    Tytgat GN; Nio CY; Schotborgh RH
    Scand J Gastroenterol Suppl; 1990; 175():1-12. PubMed ID: 1978403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.